Financial Performance - The company expects a net loss of between 80.33 million RMB and 108.68 million RMB for the fiscal year 2025, compared to a net loss of 89.66 million RMB in the same period last year[3] - The expected net loss after deducting non-recurring gains and losses is also between 80.33 million RMB and 108.68 million RMB, with a previous loss of 89.77 million RMB[3] - The company anticipates a provision for asset impairment of approximately 32 million RMB for the fiscal year 2025[5] - Non-recurring gains and losses are estimated to be around 998,000 RMB, compared to 113,800 RMB in the same period last year[5] Operating Expenses and Investments - The company has increased its sales and R&D investments, leading to higher operating expenses compared to the previous year[4] - The company has maintained its innovation investment and continues to enhance market and R&D input for its products[4] Revenue and Market Conditions - Despite significant revenue growth compared to the previous year, the overall revenue scale remains small, and increased price competition has compressed profit margins[4] Investor Guidance - The financial data for the fiscal year 2025 will be detailed in the annual report, urging investors to make cautious decisions[6]
英可瑞(300713) - 2025 Q4 - 年度业绩预告